Axonics, Inc.

19d ago, source: CNN

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel ...

Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation System

1mon ago, source: Zacks.com on MSN

Axonics, Inc. AXNX recently achieved a milestone with the CE Mark approval of its fourth-generation rechargeable Sacral ...

Axonics Stockholders Approve Merger Agreement with Boston Scientific

1mon ago, source: Yahoo Finance

IRVINE, Calif., March 22, 2024--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt Axonics’ merger agreement with Boston Scientific ...

Axonics Provides Update on Inter Partes Review Proceedings

1mon ago, source: Stockhouse

Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on two Medtronic patents that Axonics is ...

Axonics Modulation Technologies Inc (AXNX)

2d ago, source: Investing

Axonics, Inc. (AXNX) reported Q1 EPS of ($0.50), $0.12 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $48.4 million versus the consensus estimate ...

OC Leader Board: A Paradigm Change in Health Investments

3d ago, source: Orange County Business Journal

Jim Mazzo is executive chairman of Neurotech, co-founder of local business accelerator Octane, and sits on numerous boards of ...

Boston Scientific Says FTC Issues Second Request Amid Boston Scientific And Axonics Merge Review

21d ago, source: Business Insider

On January 8, Boston Scientific entered into an Agreement and Plan of Merger with Sadie Merger Sub, Inc., and Axonics, Inc., providing for the merger of merger sub with and into Axonics ...

Axonics Provides Update on Inter Partes Review Proceedings

1mon ago, source: Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on ...

Axonics Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...